In addition, we found that IRF8 binds and modulates several critical transcriptional regulators, such as RUNX1 and IRF5, which are downstream effectors of many signaling pathways [47,55], implicating a global and sophisticated regulatory function of IRF8 in AML cells. The gene discussed is IRF8; the disease is acute myeloid leukemia.